Abstract:With the advent of next-generation sequencing, an increasing number of novel gene fusions and other abnormalities have emerged recently in the spectrum of EWSR1-negative small blue round cell tumors (SBRCTs). In this regard, a subset of SBRCTs harboring either BCOR gene fusions (BCOR-CCNB3, BCOR-MAML3), BCOR internal tandem duplications (ITD), or YWHAE-NUTM2B share a transcriptional signature including high BCOR mRNA expression, as well as similar histologic features. Furthermore, other tumors such as clear cell sarcoma of kidney (CCSK) and primitive myxoid mesenchymal tumor of infancy also demonstrate BCOR ITDs and high BCOR gene expression. The molecular diagnosis of these various BCOR genetic alterations requires an elaborate methodology including custom BAC fluorescence in situ hybridization (FISH) probes and reverse transcription polymerase chain reaction assays. As these tumors show high level of BCOR overexpression regardless of the genetic mechanism involved, either conventional gene fusion or ITD, we sought to investigate the performance of an anti-BCOR monoclonal antibody clone C-10 (sc-514576) as an immunohistochemical marker for sarcomas with BCOR gene abnormalities. Thus we assessed the BCOR expression in a pathologically and genetically well-characterized cohort of 25 SBRCTs, spanning various BCOR-related fusions and ITDs and YWHAE-NUTM2B fusion. In addition, we included related pathologic entities such as 8 CCSKs and other sarcomas with BCOR gene fusions. As a control group we included 20 SBRCTs with various (non-BCOR) genetic abnormalities, 10 fusion-negative SBRCTs, 74 synovial sarcomas, 29 rhabdomyosarcomas, and other sarcoma types. In addition, we evaluated the same study group for SATB2 immunoreactivity, as these tumors also showed SATB2 mRNA upregulation. All SBRCTs with BCOR-MAML3 and BCOR-CCNB3 fusions, as well as most with BCOR ITD (93%), and all CCSKs showed strong and diffuse nuclear BCOR immunoreactivity. Furthermore, all SBRCTs with YWHAE-NUTM2B also were positive. SATB2 stain was also positive in tumors with YWHAE-NUTM2B, BCOR-MAML3, BCOR ITD (75%), BCOR-CCNB3 (71%), and a subset of CCSKs (33%). In conclusion, BCOR immunohistochemical stain is a highly sensitive marker for SBRCTs and CCSKs with BCOR abnormalities and YWHAE-rearrangements and can be used as a useful diagnostic marker in these various molecular subsets. SATB2 immunoreactivity is also present in the majority of this group of tumors.

Orbital Sarcoma with BCOR Genetic Alterations in the Pediatric Age Group

BCOR-CCNB3 Fusion and BCOR Internal Tandem Duplication in Undifferentiated Round Cell Sarcoma: a Pathologic and Molecular Study of 5 Cases.

Clear Cell Sarcomas of the Kidney Are Characterised by BCOR Gene Abnormalities, Including Exon 15 Internal Tandem Duplications and BCOR-CCNB3 Gene Fusion

BCOR-ITD Rearranged Sarcoma in the Mandible of a 5-Year-Old Child: A Case Report Highlighting Diagnostic Distinction From Odontogenic Fibromyxoma

Orbital pleomorphic sarcoma: A case report

Ocular and Orbital Tumors in Childhood

Clinical Relevance of BCOR Internal Tandem Duplication and TP53 Aberration in Clear Cell Sarcoma of the Kidney

Paediatric orbital lymphoma; a case series and review of the literature

Pediatric orbital lesions: neoplastic extraocular soft-tissue lesions

The BCOR-rearranged sarcoma involving the lung: Diagnosis with clinical outcome and literature review

BCOR-CCNB3 Sarcoma with Concurrent RNF213-SLC26A11 Gene Fusion: a Rare Sarcoma with Altered Histopathological Features after Chemotherapy

BCOR Overexpression is a Highly Sensitive Marker in Round Cell Sarcomas with BCOR Genetic Abnormalities

Primary yolk sac tumor of orbit: Report of a rare case

CNS tumor with <i>BCOR</i> internal tandem duplication: Clinicopathologic, molecular characteristics and prognosis factors

Clinicopathological Analysis of 719 Pediatric and Adolescents’ Ocular Tumors and Tumor-Like Lesions: a Retrospective Study from 2000 to 2018 in China

Benign Orbital Tumors with Bone Destruction in Children.

Clinical, pathological, and molecular features of central nervous system tumors with BCOR internal tandem duplication

Orbital Lesions: A bird's eye view of series of 2068 cases in 27 years in a tertiary care hospital in Pakistan

A Rare Case of Renal Sarcoma Mimicking Metastatic Osteosarcoma

Rare orbital cystic lesions in children.

Multiple CD34-Negative Orbital Solitary Fibrous Tumors in a Pediatric Patient